Companies: 10,795·Total market cap: $144.5T
Pro-Dex, Inc.

Pro-Dex, Inc.

PDEXNASDAQHealthcare● Active
$65.00
$-0.21(-0.32%)
Market Cap$207529400
P/E Ratio
52W High$68.99
52W Low$23.47

Pro-Dex, Inc. (PDEX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

PDEX · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$7.2M +4.5% vs prior year
FY · as of Jun 30, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$419,000
cashAndCashEquivalents
Short-Term Investments
$6.7M
shortTermInvestments
YoY Change vs Prior Year
+4.5%
vs prior fiscal year
Latest Quarter
$11.0M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$7.2MCash on Hand
Total Debt$16.6MTotal Debt
Net Cash / Net Debt−$9.4MNet Debt Position
Cash vs Debt Ratio
Cash 30%Debt 70%

Pro-Dex, Inc. carries a net debt position of $9.4M. Total debt ($16.6M) exceeds cash on hand ($7.2M). Pro-Dex, Inc. cash vs debt ratio: 30% cash / 70% debt.

Net Cash = Cash & ST Investments − Total Debt$7.2M$16.6M = −$9.4M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
PDEX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$7.2M+4.5%
Jun 30, 2024$6.8M+68.3%
Jun 30, 2023$4.1M+153.7%
Jun 30, 2022$1.6M+0.0%
Jun 30, 2021$1.6M-82.1%
PDEX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Pro-Dex, Inc.
Pro-Dex, Inc.YOU
PDEX
$7.2M3.5%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Pro-Dex, Inc. (PDEX) cash on hand as of June 30, 2025 is $7.2M, comprising $419,000 in cash and cash equivalents (CCE) plus $6.7M in short-term investments — reported as Pro-Dex, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Pro-Dex, Inc. cash reserves or cash position.

Pro-Dex, Inc. annual cash on hand history shows increased +4.5% in 2025: increased +4.5% in 2025. Pro-Dex, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Pro-Dex, Inc. carries total debt of $16.6M against cash of $7.2M, resulting in a net debt position of -$9.4M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

PDEX cash on hand · 5 questions

As of June 30, 2025, Pro-Dex, Inc. (PDEX) has $7,159,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $419,000 in cash and cash equivalents (CCE) plus $6,740,000 in short-term investments. Latest quarter (March 31, 2026): $10,979,000. Data sourced from the annual 10-K filing via FMP.

PDEX cash on handPDEX cash reservesPDEX cash 2025how much cash does PDEX have

Source: FMP /balance-sheet-statement · US GAAP · Pro-Dex, Inc. · Pro-Dex, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025